College of Medicine
Heldermon Lab
Led by Coy Heldermon · Medicine
What we study
The lab studies breast cancer treatments and lysosomal storage diseases, focusing on innovative therapies like gene and stem cell approaches. They also research patient-derived xenograft models for personalized drug testing.
What working here is like
- Wet lab
- Clinical
- Project
- 1
- Papers
- 5
Current projects
Effects of TLR4 antagonism on brain and bone function in MPS IIIB
Testing whether blocking the TLR4 immune receptor protects brain and bone in Sanfilippo syndrome type B.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for treatment of Sanfilippo syndrome type B
2026 · Molecular Genetics and Metabolism
- Assessment of the gastrointestinal manifestations of mucopolysaccharidosis type IIIB in the NAGLU knockout mouse model
2026 · Molecular Genetics and Metabolism
Show 3 more papersShow fewer
- Associations among physical activity, diet, non-lifestyle characteristics and the gut microbiome of cancer patients: A scoping review and network analysis
2026 · Oncoscience
Reviews how lifestyle and other factors affect gut bacteria in cancer patients.
- Differences in composition and diversity of the gut microbiota of post-menopausal breast cancer patients
2026 · Scientific Reports
Compares gut bacteria in post-menopausal breast cancer patients and healthy controls.
- CerS2 Is a Druggable Target in Triple-Negative Breast Cancer
2026 · Molecular Cancer Therapeutics
Identifies a drug that boosts CerS2 to kill cancer cells without harming normal cells.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Coy Heldermon hasn't set up this page yet. You can also look them up in the UF directory (search “Coy Heldermon”).